Tianren Hu

ORCID: 0000-0003-4602-8140
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Probiotics and Fermented Foods
  • Fungal and yeast genetics research
  • Yeasts and Rust Fungi Studies
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Peptides and Activities
  • Syphilis Diagnosis and Treatment
  • Plant Disease Resistance and Genetics
  • Body Image and Dysmorphia Studies
  • Plant Pathogens and Fungal Diseases
  • Fungal Biology and Applications
  • Infectious Diseases and Mycology
  • Herbal Medicine Research Studies

Shanghai Pulmonary Hospital
2024-2025

Tongji University
2024-2025

Huashan Hospital
2020-2025

Fudan University
2020-2025

State Key Laboratory of Genetic Engineering
2020-2025

Shanghai Micro Satellite Engineering Center
2023-2024

Chinese Academy of Sciences
2018-2020

University of Chinese Academy of Sciences
2018-2020

Institute of Microbiology
2018-2020

The emerging human fungal pathogen Candida auris has become a serious threat to public health. This spread 10 provinces in China as of December 2023. Here we describe 312 C. auris-associated hospitalizations and 4 outbreaks healthcare settings from 2018 Three genetic clades have been identified during this period. Molecular epidemiological analyses indicate that introduced local transmission occurred multiple instances China. Most isolated (98.7%) exhibited resistance fluconazole, while only...

10.1080/22221751.2024.2302843 article EN cc-by Emerging Microbes & Infections 2024-01-18

Morphological plasticity has historically been an indicator of increased virulence among fungal pathogens, allowing rapid adaptation to changing environments. Candida auris identified as emerging multidrug-resistant human pathogen global importance. Since the discovery this species, it thought that C. is incapable filamentous growth. Here, we report filamentation and three distinct cell types in auris: typical yeast, filamentation-competent (FC) cells. These form a novel phenotypic switching...

10.1038/s41426-018-0187-x article EN cc-by Emerging Microbes & Infections 2018-11-21

The human fungal pathogen Candida tropicalis is widely distributed in clinical and natural environments. It known to be an obligate diploid organism with incomplete atypical sexual cycle. Azole-resistant C. isolates have been observed increasing prevalence many countries recent years. Here, we report that tebuconazole (TBZ), a triazole fungicide used agriculture, can induce ploidy plasticity the formation of haploid cells . evolved strains variations exhibit cross-resistance between TBZ...

10.1371/journal.pbio.3003062 article EN cc-by PLoS Biology 2025-04-01

Candida auris is a newly emerging fungal pathogen of humans and has attracted considerable attention from both the clinical basic research communities. Clinical isolates C. are often resistant to one or more antifungal agents. To explore how resistance develops, we performed experimental evolution assays using fluconazole-susceptible isolate (BJCA001). After series passages through medium containing increasing concentrations fluconazole, cells acquired resistance. By sequencing comparing...

10.1128/aac.01466-20 article EN Antimicrobial Agents and Chemotherapy 2020-10-20

Candida vulturna belongs to the haemulonii species complex and is phylogenetically related C. auris. We report a outbreak among persons in Shanxi Province, China, during 2019-2022. Isolates were resistant multiple antifungal drugs exhibited enhanced adhesion biofilm formation properties.

10.3201/eid2907.230254 article EN cc-by Emerging infectious diseases 2023-06-15

The fungal pathogen Candida auris has emerged as a new threat to human health. We previously reported the first isolate of C. (BJCA001) in China, which belongs South Asian clade (I) and was susceptible all antifungals tested. In this study, we report isolation drug-resistant strain (BJCA002) from same city (Beijing). Strain BJCA002 African (III) is resistant fluconazole amphotericin B based on tentative MIC breakpoints. Taking advantage two isolates with distinct antifungal susceptibility...

10.1080/21505594.2021.1928410 article EN cc-by Virulence 2021-06-01
Coming Soon ...